Sort
15,842 grants matching “pancreatic cancer”
SPORE in Pancreatic Cancer
$500,000Michael A Hollingsworth · University Of Nebraska Medical Center · P50 · FY2016 · CA
LASER TISSUE WELDING: BREACHING BARRIERS IN THE SURGICAL MANAGEMENT OF THE PANCREAS
$500,000Yasmin Wadia · Laser Tissue Welding, Inc. · R44 · FY2016 · CA
Structural and Functional Biology-based analysis of non-oncogene cancer dependencies
$499,992Andrea Califano · Columbia University Health Sciences · U54 · FY2021 · CA
Specific Pathogen Free Baboon Research Resource (SPFBRR) - Administrative Supplement
$499,948Joe H. Simmons · University Of Tx Md Anderson Can Ctr · P40 · FY2021 · OD
Console for a 4.7 T small animal MRI system
$499,858Stephen B Pickup · University Of Pennsylvania · S10 · FY2008 · RR
Pharmacodynamics of Gemcitabine by MRS in Pancreatic CA
$499,767Howard S Hochster · New York University School Of Medicine · R01 · FY2006 · CA
Laser Scanning Confocal Microscope
$499,610Donna M Fekete · Purdue University · S10 · FY2010 · RR
Novel Small Molecule MDM2 Inhibitors for Pancreatic Cancer Therapy
$499,495Ruiwen Zhang · Texas Tech University Health Scis Center · R01 · FY2015 · CA
Molecular Profiling of Pancreatic Cancer
$499,461Syed Hussain · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Phase 2 Study: Intranasal Oxytocin vs. Placebo for the Treatment of Hyperphagia in Prader-Willi Syndrome [IND 121109 acknowledged 8/27/14]
$499,311Eric Hollander · Albert Einstein College Of Medicine · R01 · FY2020 · FD
Mass Cytometer CyTOF XT for Single-Cell Biology
$499,199Won Jin Ho · Johns Hopkins University · S10 · FY2024 · OD
Acquisition of a Confocal/Multiphoton Microscopy System
$499,182Robert C Burghardt · Texas A&M University · S10 · FY2006 · RR
NOMOCAN PHASE I - DEVELOPMENT OF THERAPEUTIC OR PREVENTATIVE TECHNOLOGIES FOR TREATMENT OR PREVENTION OF PEDIATRIC CANCERS AND/OR RARE CANCERS SBIR CONTRACTPHASE I - DEVELOPMENT OF THERAPEUTIC OR PRE
$499,166Ehsan Yazdi · Nomocan Pharmaceuticals, Llc · N43 · FY2025 · CA
Translating Intestinal Radioprotection by EGLN Inhibition to Improve Clinical Outcomes in Unresectable Pancreatic Cancer
$499,128Cullen Mitsuo Taniguchi · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA
9.4T NMR SPECTROMETER/IMAGER UPGRADE
$499,000University Of Pennsylvania · S10 · FY2000 · RR
Detection of in vivo enzyme activities with CEST MRI
$498,714Mark David Pagel · University Of Arizona · R01 · FY2013 · CA
Ultrasound-enhanced drug penetration for treatment of pancreatic cancer
$498,703Joo H Hwang · University Of Washington · R01 · FY2017 · CA
Cyst-X: Interpretable Deep Learning Based Risk Stratification of Pancreatic Cystic Tumors
$498,695Ulas Bagci · Northwestern University At Chicago · R01 · FY2022 · CA
Advanced Glycation End-Products and Risk of Pancreatic Cancer
$498,656Li Jiao · Baylor College Of Medicine · R01 · FY2015 · CA
A Prospective Investigation of the Oral Microbiome and Pancreatic Cancer
$498,385Julie R Palmer · Boston University Medical Campus · U01 · FY2015 · CA
Role of Altered Nutrient Metabolism in Pancreatic Cancer
$498,314Nada Y. Kalaany · Boston Children'S Hospital · R01 · FY2024 · CA
Understanding intrinsic resistance to direct KRAS inhibition in colorectal cancers
$498,202John D Gordan · University Of California, San Francisco · R37 · FY2024 · CA
Inhibiting Multi-Functional ALDOA for Cancer Therapy
$498,144Garth Powis · Phusis Therapeutics, Inc. · R01 · FY2022 · CA
Optimal control models of epithelial-mesenchymal transition for the design of pancreas cancer combination therapy
$498,111Matthew J Lazzara · University Of Virginia · U01 · FY2019 · CA
Engineering Exosome for Pancreatic Cancer Targeting Therapies
$498,038Shi-He Liu · University Of Toledo Health Sci Campus · R01 · FY2023 · CA